Juha Ranti
0000-0002-5198-2847
2 papers found
Refreshing results…
Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Early CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT
Missing publications? Search for publications with a matching author name.